obesity drug news today glp-1 september 2025 weight loss drugs leave users low on key nutrients, study finds GLP-1 drugs like Ozempic and

Subjects with baseline HbA1c above 6.0% showed 30% less VAT reduction in post-hoc trial analysis, because chronic hyperinsulinemia suppresses HSL regardless of GH levels

CagriSema demonstrates meaningfully greater weight loss than semaglutide alone (20.4% vs 14.9%), driven by the complementary amylin pathway from cagrilintide

In a properly managed clinic, infection rates are very low

This can lead to a shorter duration of B12 in the body, increasing the need for supplementation or injections to maintain adequate levels

General wear and tear from daily activities, such as walking, bending, or lifting, is a common cause of knee pain in adults

Of significance to todays popularity is evidence of GLP-1 mediated suppression of appetite via CNS targets1